Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Metacrine, Inc. MTCR NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
30/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Metacrine, Inc. (MTCR) has 12 identified peers for comparison in the Healthcare sector. Peers include ANEB, ASMB, CTMX, INDP, MGTA, MIRO and others.

People Also View

NUVB
NUVB
Nuvation Bio Inc.
$4.82
-0.72%
 CTMX
CTMX
CytomX Therapeutics, Inc.
$4.56
+0.44%
 ASMB
ASMB
Assembly Biosciences, Inc.
$29.81
+1.26%
 MNPR
MNPR
Monopar Therapeutics Inc.
$57.91
-0.02%
 SRZN
SRZN
Surrozen, Inc.
$32.02
+0.53%
 TARA
TARA
Protara Therapeutics, Inc.
$5.21
+1.56%
 MIRO
MIRO
Miromatrix Medical Inc.
$3.39
+0.59%
 TIL
TIL
Instil Bio, Inc.
$8.89
+5.33%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message